Matsushita H - Search Results

1

Exploring immune therapy for renal cancer.

Matsushita H, Kakimi K, Tomita Y, Tatsugami K, Naito S, Suekane S, Noguchi M, Moriya F, Matsuoka K, Itoh K, Kobayashi H, Eto M, Takahashi W, Kawano Y, Wada Y. Matsushita H, et al. Int J Urol. 2011 Jun;18(6):412-21. doi: 10.1111/j.1442-2042.2011.02762.x. Int J Urol. 2011. PMID: 21599759 No abstract available.

2

Adoptive immunotherapy for advanced non-small cell lung cancer using zoledronate-expanded γδTcells: a phase I clinical study.

Sakamoto M, Nakajima J, Murakawa T, Fukami T, Yoshida Y, Murayama T, Takamoto S, Matsushita H, Kakimi K. Sakamoto M, et al. Among authors: matsushita h. J Immunother. 2011 Mar;34(2):202-11. doi: 10.1097/CJI.0b013e318207ecfb. J Immunother. 2011. PMID: 21304399 Clinical Trial.

3

Targeting spatiotemporal expression of CD137 on tumor-infiltrating cytotoxic T lymphocytes as a novel strategy for agonistic antibody therapy.

Noji S, Hosoi A, Takeda K, Matsushita H, Morishita Y, Seto Y, Kakimi K. Noji S, et al. Among authors: matsushita h. J Immunother. 2012 Jul;35(6):460-72. doi: 10.1097/CJI.0b013e31826092db. J Immunother. 2012. PMID: 22735804

4

[Dendritic cells for cancer immunotherapy].

Kakimi K, Kondo A, Matsushita H. Kakimi K, et al. Among authors: matsushita h. Nihon Rinsho. 2012 Dec;70(12):2130-5. Nihon Rinsho. 2012. PMID: 23259385 Review. Japanese.

5

Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.

Hosoi A, Matsushita H, Shimizu K, Fujii S, Ueha S, Abe J, Kurachi M, Maekawa R, Matsushima K, Kakimi K. Hosoi A, et al. Among authors: matsushita h. Int J Cancer. 2014 Apr 15;134(8):1810-22. doi: 10.1002/ijc.28506. Epub 2013 Oct 21. Int J Cancer. 2014. PMID: 24150772 Free article.

6

Intraperitoneal injection of in vitro expanded Vγ9Vδ2 T cells together with zoledronate for the treatment of malignant ascites due to gastric cancer.

Wada I, Matsushita H, Noji S, Mori K, Yamashita H, Nomura S, Shimizu N, Seto Y, Kakimi K. Wada I, et al. Among authors: matsushita h. Cancer Med. 2014 Apr;3(2):362-75. doi: 10.1002/cam4.196. Epub 2014 Feb 7. Cancer Med. 2014. PMID: 24515916 Free PMC article. Clinical Trial.

7

γδ T cell therapy for the treatment of non-small cell lung cancer.

Kakimi K, Matsushita H, Murakawa T, Nakajima J. Kakimi K, et al. Among authors: matsushita h. Transl Lung Cancer Res. 2014 Feb;3(1):23-33. doi: 10.3978/j.issn.2218-6751.2013.11.01. Transl Lung Cancer Res. 2014. PMID: 25806278 Free PMC article. Review.

8

Identification of Individual Cancer-Specific Somatic Mutations for Neoantigen-Based Immunotherapy of Lung Cancer.

Karasaki T, Nagayama K, Kawashima M, Hiyama N, Murayama T, Kuwano H, Nitadori J, Anraku M, Sato M, Miyai M, Hosoi A, Matsushita H, Kikugawa S, Matoba R, Ohara O, Kakimi K, Nakajima J. Karasaki T, et al. Among authors: matsushita h. J Thorac Oncol. 2016 Mar;11(3):324-33. doi: 10.1016/j.jtho.2015.11.006. Epub 2015 Dec 29. J Thorac Oncol. 2016. PMID: 26752676 Free article.

9

Neoantigen Load, Antigen Presentation Machinery, and Immune Signatures Determine Prognosis in Clear Cell Renal Cell Carcinoma.

Matsushita H, Sato Y, Karasaki T, Nakagawa T, Kume H, Ogawa S, Homma Y, Kakimi K. Matsushita H, et al. Cancer Immunol Res. 2016 May;4(5):463-71. doi: 10.1158/2326-6066.CIR-15-0225. Epub 2016 Mar 15. Cancer Immunol Res. 2016. PMID: 26980598

10

Advances in personalized cancer immunotherapy.

Kakimi K, Karasaki T, Matsushita H, Sugie T. Kakimi K, et al. Among authors: matsushita h. Breast Cancer. 2017 Jan;24(1):16-24. doi: 10.1007/s12282-016-0688-1. Epub 2016 Mar 21. Breast Cancer. 2017. PMID: 27000871 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

968 results

Search Page